Sign in

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München MUV2.DE

Price 528.0 EUR
as of 2026-09-05
56/100
Mixed
Quality50
Growth34
Balance-sheet strength48
Valuation80
Momentum58
Income91

Composite 56/100; the shares have moved about 20% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 34/100 — a moderate mark against it.

Case for

Income ranks 91/100 — a strong point in its favour. Valuation ranks 80/100 — a strong point in its favour. Momentum ranks 58/100 — a slight point in its favour.

Case against

Growth ranks 34/100 — a moderate mark against it. Balance-sheet strength ranks 48/100 — a slight mark against it.

What the company does Münchener Rückversicherungs-Gesellschaft (MUV2.DE) is a global reinsurer operating through six segments, including Life and Health Reinsurance and Property-Casualty Reinsurance. It offers advanced analytics, digital underwriting, and NatCatSERVICE for natural catastrophe risk assessment.

Key financials MUV2.DE reports a ROE of 19.9%, net margins of 11.0%, and revenue growth of -6.0% with EPS growth of 60.8%. Debt/Equity is 0.22, and the dividend yield is 4.6% with a payout ratio of 38.3%.

Stock health The stock has a beta of 0.33, a current ratio of 0.29, and a Piotroski F-Score of 5/9. Momentum shows 3m +2.62%, 6m +7.61%, and 12m -4.15%, with RSI(14) at 67.00.

Price vs fair value The stock trades at a **discount** of 49.40% to our fair-value estimate (783.16) and a **discount** of 5.33% to the analyst 12-month target (552.13). - High profitability (ROE 19.9%) supports valuation (Valuation percentile 78.0) (Sideravia). - Weak revenue growth (-6.0%) and low current ratio (0.29) may explain the discount (Key Financials). - Moderate momentum (RSI 67.00) suggests limited near-term upside (Momentum).

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.